ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

INN Innovision Res.

34.75
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Innovision Res. LSE:INN London Ordinary Share GB0030308448 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 34.75 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

AGM Statement

29/08/2003 8:00am

UK Regulatory


RNS Number:1472P
Innovision Research&Technology PLC
29 August 2003


                      Innovision Research & Technology plc


                               2003 AGM Statement


At the Annual General Meeting of Innovision Research & Technology plc at 4.30 pm
on 28 August 2003, Barton Clarke CBE, Chairman, made the following comments:

"Further to my statement in the annual report in June, I am pleased to announce
continued progress within the business.

On the commercial front, we have seen excellent advances on the two significant
contracts announced earlier this year:

   *Phase one of the consumer goods project, originally announced in February
    2003, has been successfully completed and we have this week commenced the
    next major phase of work on this important project.

   *Work for our European Telecommunications customer continues apace with a
    number of technical challenges recently overcome, and requests for
    additional work now being incorporated.

Within the medical sector, we have now started full development on a key project
for a major European customer and are undertaking further feasibility studies
for, amongst others, a major US medical devices company. These recent successes
confirm our belief in the medical sector as one to which Innovision Research &
Technology's unique mix of skills are particularly suited.

On other projects, engineering work remains on target, generating solid revenue
growth, and we continue to build a strong funnel of sales leads to maintain the
momentum achieved in the last nine months. The progress made reflects the hard
work and commitment of the whole team. For personal reasons, and following the
successful reduction in our toy focus Andrew White, our Director of Innovation,
will now move to a part-time role within the Company. He will remain an
Executive Director and will continue to concentrate on ensuring that the
innovation and creativity on which the company thrives is reinforced across the
business.

Overall I am pleased with current progress and although challenges remain, the
recent successes serve to reinforce our confidence in the long-term potential of
our business. "


Enquires:

Innovision Research & Technology plc                Tel: 0118 936 6311
Mike Wroe, Finance Director



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
AGMNKFKNABKDFFB

1 Year Innovision Research&technology Chart

1 Year Innovision Research&technology Chart

1 Month Innovision Research&technology Chart

1 Month Innovision Research&technology Chart

Your Recent History

Delayed Upgrade Clock